Souhaitez-vous accéder aux communiqués récents ?

WALTHAM, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) is pleased to announce that Canada’s Drug Agency (CDA) has issued a positive reimbursement...

Opus Genetics Provides BEST1 Program Update with Detailed Timeline for OPGx-BEST1 Results

The Elecsys IGRA TB test expands global access to tuberculosis infection testing, advancing progress toward the World Health Organization's elimination targets.Performed on Roche’s industry-leading...

Cascade Prodrug and Uneedle advance CPD100 for wet AMD using Bella-Vue suprachoroidal delivery, with preclinical work underway.

Exton, PA, July 08, 2026 (GLOBE NEWSWIRE) -- The European market for metabolic dysfunction-associated steatohepatitis (MASH) is entering a pivotal phase of development as increasing disease...

The opening of SBC MEN'S FLASH CLINIC Ikebukuro, a clinic dedicated exclusively to men's beard hair removal, in Tokyo on August 6, 2026.

Pasithea Therapeutics Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit on July 16 in Boston

Exton, PA, July 07, 2026 (GLOBE NEWSWIRE) -- While the treatment landscape for systemic lupus erythematosus (SLE) continues to evolve with increasing biologic adoption and a growing pipeline of...

London Business School has announced a landmark £25 million gift from the David and Molly Pyott Foundation and David and Molly Pyott

Peer-reviewed preclinical melanoma research finds Provectus’s synthetic small molecule can both stimulate anti-tumor immunity and suppress peripheral immune cells at the same dose. A recently...